サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1496879

椎体形成術（VertebroplastyおよびKyphoplasty）の世界市場：2024～2031年

Global Vertebroplasty and Kyphoplasty Market - 2024-2031

出版日
ページ情報
英文 182 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.90円
椎体形成術（VertebroplastyおよびKyphoplasty）の世界市場：2024～2031年
出版日: 2024年06月18日
発行: DataM Intelligence
ページ情報: 英文 182 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

概要

世界の椎体形成術（VertebroplastyおよびKyphoplasty）市場は、2023年に12億米ドルに達し、2031年には17億米ドルに達すると予測され、予測期間2024年～2031年CAGRは5%で成長する見込みです。

椎体形成術（VertebroplastyおよびKyphoplasty）は、椎体圧迫骨折による痛み治療ため比較的新しい技術であり、脊椎を安定させることで、脊椎機能障害拡大を防ぎ、生活質を向上させます。

前弯形成術は椎体形成術とは異なり、まず椎体内でバルーンを膨らませて空洞を作り、そこにセメントを低圧で注入します。前弯症は、骨粗鬆症やがん、そ他疾患によって引き起こされる椎体圧迫骨折を安定させるために用いられる最新脊椎外科手術です。

市場は、低侵襲手術採用増加、骨粗鬆症と脊椎疾患罹患率上昇、老人人口増加、事故事例増加、ヘルスケアにおける技術進歩など要因によって牽引されています。

市場力学

促進要因

骨粗鬆症と脊椎疾患の発生率の増加

世界の椎体形成術（VertebroplastyおよびKyphoplasty）市場の需要は、複数の要因によって牽引されています。骨粗鬆症は、米国で広く蔓延している公衆衛生上の問題です。米国の外科医総長は最近、骨粗鬆症の重要性について米国人に特別な注意を喚起しています。広範な研究によると、椎体圧迫骨折は骨粗鬆症の最も一般的な合併症の一つです。

白人女性の骨粗鬆症性脊椎骨折の生涯リスクは15.6％です。米国では毎年、骨粗鬆症に続発する椎体骨折が70万件以上診断され、11万5,000件の入院に至っています。骨粗鬆症性圧迫骨折の主な結果は、背中の痛み、後弯、身長の低下です。

さらに、この業界の主要企業が新製品や新技術を発表することは、この市場の成長を促進すると思われます。例えば、2023年10月、オランダに本社を置き、脊椎損傷用の次世代インプラントを開発しているアンバーインプラント社は、VCFix脊椎システムの臨床試験を開始しました。このインプラントは、ペディクル・アンカーレッジを介して脊柱の荷重分散を最適化しようとするものです。

ヒトを対象とした初の臨床試験では、椎体圧迫骨折患者に対するVCFixの安全性と有効性が評価されます。また、トレーサビリティを確保し、感染リスクを低減するため、単回使用の滅菌済み手術キットが付属します。

また、IZI Medicalは2021年8月、椎体形成術（VertebroplastyおよびKyphoplasty）におけるセメント注入時のリアルタイムの流れの可視化のニーズに対応することを目的とした製品、Vertefix HVセメントを正式に発売しました。

抑制要因

治療に伴う高額な費用、厳しい規制の枠組み、手技に伴う合併症、熟練した専門家の不足、限られた償還政策などの要因が市場の妨げになると予想されます。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

  • 影響要因
    • 促進要因
      • 骨粗鬆症と脊椎疾患の増加
      • 低侵襲手術の採用の増加
      • 老人人口の増加
      • ヘルスケアにおける技術の進歩
    • 抑制要因
      • 治療に伴う高コスト
      • 熟練した専門家の不足
    • 機会
    • 影響分析

第5章 産業分析

  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • 価格分析
  • 規制分析
  • アンメットニーズ
  • PESTEL分析
  • 特許分析
  • SWOT分析

第6章 COVID-19分析

第7章 デバイスタイプ別

  • Vertebroplastyデバイス
    • 針
    • セメント混合・供給デバイス
    • X線デバイス
  • Kyphoplastyデバイス
    • 針
    • バルーン
    • X線デバイス

第8章 用途別

  • 外傷性椎体骨折
  • 骨粗鬆症性椎体骨折

第9章 エンドユーザー別

  • 病院
  • 外来手術センター
  • 専門クリニック

第10章 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • その他欧州
  • 南米
    • ブラジル
    • アルゼンチン
    • その他南米
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋地域
  • 中東・アフリカ

第11章 競合情勢

  • 競合シナリオ
  • 市況/シェア分析
  • M&A分析

第12章 企業プロファイル

  • Medtronic
    • 会社概要
    • 製品ポートフォリオと説明
    • 財務概要
    • 主な発展
  • Jayon Implants
  • Johnson & Johnson
  • Joimax
  • Teknimed
  • Globus Medical
  • Stryker
  • MEDAID Inc
  • Biopsybell
  • Merit Medical Systems

第13章 付録

目次
Product Code: MD1543

Overview

The global vertebroplasty and kyphoplasty market reached US$ 1.2 billion in 2023 and is expected to reach US$ 1.7 billion by 2031, growing at a CAGR of 5% during the forecast period 2024-2031.

Vertebroplasty and kyphoplasty are relatively new techniques for the treatment of pain caused by vertebral body compression fractures and stabilize the spine, thereby preventing further spinal dysfunction and improving quality of life.

Kyphoplasty differs from vertebroplasty in that a balloon is first inflated in the vertebral body to create a cavity into which cement is then injected under lower pressure. Kyphosis is a modern spine surgery procedure used to stabilize vertebral compression fractures caused by osteoporosis, cancer, and other conditions.

The market is driven by factors such as a rise in the adoption of minimally invasive surgeries, a rising incidence of osteoporosis & spinal disorders, an increase in the geriatric population, a rise in accidental cases, and technological advancements in healthcare.

Market Dynamics

Drivers

Rising Incidence of Osteoporosis & Spinal Disorders

The demand for the global vertebroplasty and kyphoplasty market is driven by multiple factors. Osteoporosis is a widespread public health problem in the United States. The surgeon general of the United States has recently introduced special attention to the importance of osteoporosis to Americans extensive study states that vertebral body compression fractures are among the most common complications of osteoporosis.

The lifetime risk of osteoporotic spine fracture in white women is 15.6%. Each year, more than 700,000 vertebral body fractures secondary to osteoporosis are diagnosed in the United States, resulting in 115,000 hospital admissions. The major consequences of osteoporotic compression fractures are back pain, kyphosis, and height loss.

Moreover, major key players in the industry launching new products and technology would propel this market growth. For instance, in October 2023, Amber Implants, a Netherlands-based company developing next-gen implants for spinal injuries, began clinical trials for its VCFix spinal system. The implant seeks to optimize load distribution in the spine via pedicle anchorage.

The first-in-human trial will evaluate VCFix's safety and efficacy for patients with vertebral compression fractures. It's also included with a single-use, sterile surgical kit to ensure traceability and reduce infection risk.

Also, in August 2021, IZI Medical officially launched Vertefix HV Cement, a product which aims to address the need for real-time flow visualization during cement injection for vertebroplasty and kyphoplasty procedures.

Restraints

Factors such as the high cost associated with the treatment, stringent regulatory framework, complications associated with the procedures, lack of skilled professionals, and limited reimbursement policies are expected to hamper the market.

For more details on this report - Request for Sample

Segment Analysis

The global vertebroplasty and kyphoplasty market is segmented based on device type, application, end-user, and region.

The kyphoplasty device segment accounted for approximately 62.5% of the global vertebroplasty and kyphoplasty market share

The kyphoplasty segment is expected to hold the largest market share over the forecast period owing to the advantages that kyphoplasty provides over vertebroplasty, such as reduction in back pain, as well as restoration of vertebral body height, and a lower rate of cement extravasation. This is mainly done by placing balloons to gently elevate the fractured vertebrae in an attempt to return them to the correct position.

According to the study published in Frontiers in Surgery Journal in July 2022, the use of kyphoplasty for the clinical treatment of osteoporotic vertebral compression fractures, spinal metastatic tumors, hemangiomas, myelomas, and vertebral nonunion has increased with the global development of minimally invasive spinal surgery.

Therefore, the rising adoption of kyphoplasty procedures for the treatment of vertebral compression fractures and cancers will lead to increased adoption of kyphoplasty devices, expected to drive the segment's growth.

Geographical Analysis

North America accounted for approximately 42.3% of the global vertebroplasty and kyphoplasty market share

North America region is expected to hold the largest market share over the forecast period owing to factors such as better healthcare infrastructure, rising funding from the government, awareness among people and healthcare industry stakeholders about available technologies, and the high concentration of market players in the region.

For instance, in September 2022, RevBio was awarded a Phase I Small Business Innovation Research (SBIR) grant from the National Institutes of Health. With the help of this grant, the company will be able to develop Tetranite, a patented bone adhesive technology, for the treatment of vertebral compression fractures.

Therefore, such funding for the development of technologies in vertebral compression fractures is expected to drive market growth due to the increased launch and adoption of products in the market over the forecast period.

Furthermore, according to Osteoporosis Canada, 2022, more than 2.3 million Canadians are living with osteoporosis and at least 1 in 3 women and 1 in 5 men suffer from an osteoporotic fracture during their lifetime. Such a huge prevalence of osteoporosis in Canada is expected to increase the adoption of vertebroplasty and kyphoplasty procedures in the Canadian population, thereby leading to the rising adoption of vertebroplasty and kyphoplasty devices, driving the market growth.

COVID-19 Impact Analysis

The COVID-19 pandemic significantly impacted the global vertebroplasty and kyphoplasty market. Hospital admissions for patients other than COVID-19 and serious diseases were restricted to hospitals to avoid the spread of the virus.

For instance, according to the study published in SAGE Journals in April 2022, there have been noticeable changes in the hospital admissions of patients with vertebral compression fractures (VCF) compared to the period before the COVID-19 pandemic. Fewer patients visited the emergency department for VCF during the peak of the Covid-19 pandemic which represented a 44% decrease. Hence, COVID-19 affected the pace of the market at the beginning of the pandemic.

Market Segmentation

By Device Type

  • Vertebroplasty Device
    • Needle
    • Cement Mixing & Delivery Devices
    • X-ray Device
  • Kyphoplasty Device
    • Needle
    • Balloon
    • X-ray Device

By Application

  • Traumatic Vertebral Fractures
  • Osteoporotic Vertebral Fractures

By End-User

  • Hospitals
  • Ambulatory Surgical Centers
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • U.K.
    • France
    • Spain
    • Italy
    • Rest of Europe
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Middle East and Africa

Competitive Landscape

The major global players in the vertebroplasty and kyphoplasty market include Medtronic, Jayon Implants, Johnson & Johnson, Joimax, Teknimed, Globus Medical, Stryker, MEDAID Inc, Biopsybell, and Merit Medical Systems among others.

Key Developments

  • In August 2023, Safe Orthopaedics SAS reported results from a biomechanical study comparing its new surgical technique Sycamore a pedicle-anchored implant with standalone balloon kyphoplasty.
  • In October 2022, Halma announced the acquisition of IZI Medical Products, a leading designer, manufacturer, and distributor of medical devices used across a range of diagnostic and therapeutic procedures. IZI Medical Products offers vertebroplasty and kyphoplasty products such as DURO-JECT Bone Cement Injector Set, Vertefix HV High Viscosity Bone Cement, and Kiva VCF Treatment System, which further expands Halma's product portfolio.
  • In April 2022, Nanox announced FDA approval for HealthOST Device, an AI software monitoring vertebral compression fractures and low bone density, which are frequently associated with osteoporosis.
  • In February 2022, Enlife Solutions represented Tecres, an Italian company in Romania. The representation includes a spinal and cranial portfolio of Tecres, including a Mendec spine vertebroplasty kit for osteoporosis.

Why Purchase the Report?

  • To visualize the global vertebroplasty and kyphoplasty market segmentation based on device type, application, end-user, and region as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development
  • Excel data sheet with numerous data points of global vertebroplasty and kyphoplasty market level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping is available in excel consisting of key products of all the major players.

The global vertebroplasty and kyphoplasty market report would provide approximately 62 tables, 55 figures, and 182 Pages.

Target Audience 2024

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Device Type
  • 3.2. Snippet by Application
  • 3.3. Snippet by End-User
  • 3.4. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Rising Incidence of Osteoporosis & Spinal Disorders
      • 4.1.1.2. Rise in the Adoption of Minimally Invasive Surgeries
      • 4.1.1.3. Increase in the Geriatric Population
      • 4.1.1.4. Technological Advancements in Healthcare
    • 4.1.2. Restraints
      • 4.1.2.1. High Cost Associated with the Treatment
      • 4.1.2.2. Lack of Skilled Professionals
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. Unmet Needs
  • 5.6. PESTEL Analysis
  • 5.7. Patent Analysis
  • 5.8. SWOT Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID
    • 6.1.2. Scenario During COVID
    • 6.1.3. Scenario Post COVID
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During the Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Device Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
    • 7.1.2. Market Attractiveness Index, By Device Type
  • 7.2. Vertebroplasty Device*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
    • 7.2.3. Needle
    • 7.2.4. Cement Mixing & Delivery Devices
    • 7.2.5. X-ray Device
  • 7.3. Kyphoplasty Device
    • 7.3.1. Needle
    • 7.3.2. Balloon
    • 7.3.3. X-ray Device

8. By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application
  • 8.2. Traumatic Vertebral Fractures *
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Osteoporotic Vertebral Fractures

9. By End-User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.1.2. Market Attractiveness Index, By End-User
  • 9.2. Hospitals *
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Ambulatory Surgical Centers
  • 9.4. Specialty Clinics

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. UK
      • 10.3.6.3. France
      • 10.3.6.4. Italy
      • 10.3.6.5. Spain
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. South Korea
      • 10.5.6.5. Rest of Asia-Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

  • 12.1. Medtronic *
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio & Description
    • 12.1.3. Financial Overview
    • 12.1.4. Key Developments
  • 12.2. Jayon Implants
  • 12.3. Johnson & Johnson
  • 12.4. Joimax
  • 12.5. Teknimed
  • 12.6. Globus Medical
  • 12.7. Stryker
  • 12.8. MEDAID Inc
  • 12.9. Biopsybell
  • 12.10. Merit Medical Systems

LIST NOT EXHAUSTIVE

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us